Understanding the Role of GSK-3 in C/EBPα Regulation
Author Information
Author(s): H-K Liu, S Perrier, C Lipina, D Finlay, H McLauchlan, C J Hastie, H S Hundal, C Sutherland
Primary Institution: University of Dundee
Hypothesis
Is C/EBPα a link between GSK3 and gluconeogenic gene promoters?
Conclusion
C/EBPα is not regulated by GSK3 phosphorylation in liver cells, but it does play a role in adipocyte regulation.
Supporting Evidence
- C/EBPα represses the IGFBP1 TIRE, but mutations at T222 or T226 do not affect its activity.
- GSK3 inhibition reduces phosphorylation of T222/T226 in intact cells.
- C/EBPα is a poor substrate for GSK3 in vitro.
- Insulin does not alter T222/226 phosphorylation in liver cells.
Takeaway
This study looks at how a protein called C/EBPα is controlled by another protein, GSK3, and finds that GSK3 doesn't actually change how C/EBPα works in liver cells.
Methodology
The study involved transfecting cells with various C/EBPα constructs and measuring their activity and phosphorylation status.
Limitations
The study primarily focuses on cell lines, which may not fully represent in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website